Connecting ALS: How New Drug Coverage Decisions Are Made
In this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
WATCH TIME: 16 minutes
Once the FDA approves a drug, payors such as Medicare, the Veterans Administration, and commercial insurance companies have to decide how much they will pay for the drug. In this episode, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, talks to the Connecting ALS podcast about how drug coverage decisions are made.
Connecting ALS is a weekly podcast produced by The ALS Association in partnership with CitizenRacecar. Each episode aims to discuss research and technology developments, highlight advocacy efforts, and share the personal stories woven through the community of amyotrophic lateral sclerosis (ALS). For more information on The ALS Association, you can visit: ALS.org.
You can also find the show on Facebook and Twitter to join in the conversation, and you can subscribe on your favorite podcast app.
